-
Full of Sound and Fury: But does America’s Medicaid debate signify anything for global health? Bi-weekly Checkup (5/10/13)
As BoP countries seek to improve health outcomes and increase access to care, there are a lot of questions about what’s the most workable approach. Unfortunately, in the U.S., a recent study on the effectiveness of public health insurance has produced a lot more heat than light. We take a look at the controversy, along with other posts you might have missed, in NextBillion Health Care’s Bi-Weekly Checkup.
- Categories
- Education, Health Care
- Tags
- public health, research
-
Cancer Vaccines Get a Price Cut in Poor Nations
The two companies that make vaccines against cervical cancer announced Thursday that they would cut their prices to the world’s poorest countries below $5 per dose.
- Categories
- Health Care
- Tags
- public health
-
At Long Last: Is mental health poised to take its place on the global health agenda?
Mental illness is a taboo that extends across cultures - and that stigma is one reason it has traditionally been an afterthought in global health discussions. But there’s a growing sense that this may be changing. As mental health seems poised to emerge as a major priority on the global health agenda, we’ve assembled this series of video presentations and interviews with global mental health practitioners, researchers and advocates.
- Categories
- Health Care
- Tags
- public health
-
Preventing Drug Shortages With Cell Phones in Malawi
Eighty percent of the 13 million Malawians live in rural areas, making delivering health services challenging, especially in remote parts with no roads.
- Categories
- Health Care, Technology
- Region
- Sub-Saharan Africa
-
One Step Closer to Ending Malaria: Public-private partnerships tap the potential of synthetic anti-malarial treatment
PATH and its partners in the public and private sector recently began producing a new synthetic version of artemisinin, the key ingredient in the gold-standard malaria treatment. This promises to bolster the existing botanical supply and meet approximately one-third of the global demand. According to PATH CEO Steve Davis, this milestone shows the strength of collaboration across the public and private sectors to advance science for the benefit of global health.
- Categories
- Health Care
-
Big Pharma in Africa: Weighing corporate citizenship and the bottom line
In the early 2000s, pharmaceutical companies were high on activists’ hit lists. Today, the discourse seems merrier.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- public health
-
Pharmacovigilance Reporting Goes Digital in Kenya
Monitoring and reporting of adverse drug reactions (ADRs) and poor-quality human medicines has gone digital in Kenya.
- Categories
- Health Care, Impact Assessment
-
Unhealthy Hospitals
The future of Afghanistan begins at the end of next year, after U.S. combat troops depart and Afghan forces take over for keeps.
- Categories
- Health Care
- Region
- North Africa & Near East
- Tags
- public health